Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China )
Also on site :
- Syria Launches New National Visual Identity
- Supreme Court clears way for deportation to South Sudan of several immigrants with no ties there
- Little Debbie's Surprising New Treat Leaks and Fans Want '15 of Them'